0
Skip to Content
DR DAN REARDON
Home
About
Contact
GLP-1 Exit Strategy
Deprescribing
Clinical Data Review
Metabolic Review
Fees
Book an appointment
DR DAN REARDON
Home
About
Contact
GLP-1 Exit Strategy
Deprescribing
Clinical Data Review
Metabolic Review
Fees
Book an appointment
Home
About
Contact
Folder: Services
Back
GLP-1 Exit Strategy
Deprescribing
Clinical Data Review
Metabolic Review
Fees
Book an appointment
Why GLP-1 Drugs Work Better for Some People Than Others
Clinical Evidence Dr Dan Reardon 09/04/2026 Clinical Evidence Dr Dan Reardon 09/04/2026

Why GLP-1 Drugs Work Better for Some People Than Others

A contrarian look at why GLP-1 drugs work differently, what the new genetics paper actually shows, and what patients should do with that information.

Read More
SURMOUNT-1 Trial Summary: What Tirzepatide Actually Showed
Evidence Briefings Dr Dan Reardon 08/04/2026 Evidence Briefings Dr Dan Reardon 08/04/2026

SURMOUNT-1 Trial Summary: What Tirzepatide Actually Showed

A plain-English summary of SURMOUNT-1: how effective tirzepatide was in obesity, who the study applied to, and what it still did not answer.

Read More
STEP 1 Trial Summary: What Semaglutide Actually Showed
Evidence Briefings Dr Dan Reardon 08/04/2026 Evidence Briefings Dr Dan Reardon 08/04/2026

STEP 1 Trial Summary: What Semaglutide Actually Showed

A plain-English summary of STEP 1: how much weight semaglutide produced, who the trial applied to, and what it did not prove.

Read More
What Happens When Tirzepatide Is Stopped? What SURMOUNT-4 Showed
Evidence Briefings Dr Dan Reardon 08/04/2026 Evidence Briefings Dr Dan Reardon 08/04/2026

What Happens When Tirzepatide Is Stopped? What SURMOUNT-4 Showed

A clear summary of SURMOUNT-4: what happened when tirzepatide was continued, what happened when it was withdrawn, and why that matters for maintenance.

Read More
What Happens When Semaglutide Is Stopped? What STEP 4 Showed
Evidence Briefings Dr Dan Reardon 07/04/2026 Evidence Briefings Dr Dan Reardon 07/04/2026

What Happens When Semaglutide Is Stopped? What STEP 4 Showed

A clear, evidence-led summary of STEP 4: what happened when semaglutide was continued, what happened when it was stopped, and why that matters clinically.

Read More
Foundayo: What Lilly’s New Weight Loss Pill Really Means
Clinical Evidence Dr Dan Reardon 02/04/2026 Clinical Evidence Dr Dan Reardon 02/04/2026

Foundayo: What Lilly’s New Weight Loss Pill Really Means

Foundayo is Lilly’s new oral GLP-1 pill for weight loss. Here is what it does, how it compares, side effects, and why convenience is not the whole story.

Read More
Retatrutide Phase 3 Diabetes Results: What They Actually Show
Clinical Evidence Dr Dan Reardon 26/03/2026 Clinical Evidence Dr Dan Reardon 26/03/2026

Retatrutide Phase 3 Diabetes Results: What They Actually Show

Retatrutide’s phase 3 diabetes data look strong on A1C and weight loss. Here is what the trial showed, what most coverage misses, and what patients should do now.

Read More
Coming Off Mounjaro (Tirzepatide): What to Expect, Week By Week
GLP-1, Weight Medicine Dr Dan Reardon 26/02/2026 GLP-1, Weight Medicine Dr Dan Reardon 26/02/2026

Coming Off Mounjaro (Tirzepatide): What to Expect, Week By Week

Stopping Mounjaro? Appetite often returns as tirzepatide clears (~4–5 weeks). Here’s what studies show about regain, and a calm off-ramp plan.

Read More
Deprescribing Dr Dan Reardon 17/02/2026 Deprescribing Dr Dan Reardon 17/02/2026

Statins: when stopping is appropriate (and when it isn’t)

Read More
Deprescribing Dr Dan Reardon 01/02/2026 Deprescribing Dr Dan Reardon 01/02/2026

PPI rebound explained

Read More
SSRI Withdrawal vs Relapse: How to Tell the Difference (Without Guesswork)
Deprescribing Dr Dan Reardon 01/01/2026 Deprescribing Dr Dan Reardon 01/01/2026

SSRI Withdrawal vs Relapse: How to Tell the Difference (Without Guesswork)

Are brain zaps, dizziness, anxiety, withdrawal or relapse? Research-backed signs, timelines, and why studies can confuse the two. Plus tapering & FAQs.

Read More
Coming Off Wegovy and Ozempic: The Evidence-Backed Semaglutide Off-Ramp
GLP-1, Weight Medicine Dr Dan Reardon 01/12/2025 GLP-1, Weight Medicine Dr Dan Reardon 01/12/2025

Coming Off Wegovy and Ozempic: The Evidence-Backed Semaglutide Off-Ramp

Stopping semaglutide? Here’s what studies show about appetite return, weight regain, timelines (5–7 weeks), and practical off-ramp strategies.

Read More

Not urgent care. If you have acute symptoms or feel unwell, contact your GP, NHS 111, or in an emergency call 999.

To book a consultation

Call: 0121 308 7774

Email: Dr Dan Reardon

Book an appointment
Book an appointment

What I do

Deprescribing

Metabolic Health

Clinical Data Review

Contact

Credentials / Legal

Dr Dan Reardon, MB ChB, BSc, MSc

GMC number: 6098984

Privacy Policy / Cookies / Terms

Medical disclaimer / Complaints

About

Lifestyle medicine with clinical judgement. Dr Dan Reardon provides private consultations in deprescribing, metabolic health optimisation, and clinical data review—for people who want a clear plan built around real life, not generic protocols.

Where a prescription is clinically appropriate, this can be arranged via SignatureRx and delivered to your home or nominated address.

Sutton Coldfield • Birmingham • Solihull • Lichfield • Tamworth • Walsall

Consultations delivered via: Sutton Medical Consulting · Ashfurlong Medical Centre, 233 Tamworth Road, Sutton Coldfield, West Midlands, B75 6DX

Copyright Instedify Limited trading as Dr Dan Reardon 2026 - All right reserved